PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $23,837,000 | -44.4% | 776,456 | +21.3% | 0.00% | -42.9% |
| Q3 2016 | $42,908,000 | +147.2% | 639,937 | +9.8% | 0.01% | +133.3% |
| Q2 2016 | $17,355,000 | +1.0% | 582,564 | -0.4% | 0.00% | 0.0% |
| Q1 2016 | $17,181,000 | -61.6% | 584,979 | +2.5% | 0.00% | -57.1% |
| Q4 2015 | $44,754,000 | +0.6% | 570,847 | -3.3% | 0.01% | -12.5% |
| Q3 2015 | $44,484,000 | -35.3% | 590,290 | +0.3% | 0.01% | -27.3% |
| Q2 2015 | $68,730,000 | -48.8% | 588,693 | +3.5% | 0.01% | -47.6% |
| Q1 2015 | $134,235,000 | +27.7% | 568,529 | +2.4% | 0.02% | +23.5% |
| Q4 2014 | $105,119,000 | -20.4% | 555,391 | +0.4% | 0.02% | -22.7% |
| Q3 2014 | $132,027,000 | +235.2% | 553,410 | -7.3% | 0.02% | +214.3% |
| Q2 2014 | $39,392,000 | -33.4% | 596,848 | +5.2% | 0.01% | -30.0% |
| Q1 2014 | $59,111,000 | +18.4% | 567,607 | +17.7% | 0.01% | +11.1% |
| Q4 2013 | $49,923,000 | +207.6% | 482,204 | +59.5% | 0.01% | +200.0% |
| Q3 2013 | $16,228,000 | +41.9% | 302,414 | +17.3% | 0.00% | +50.0% |
| Q2 2013 | $11,440,000 | – | 257,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |